Successful SAFE-T midterm review at the IMI JU
This is a brief update on our midterm review at the IMI-JU on Nov 29. We had a really great meeting with four external reviewers (Paul Watkins, Maria Luisa Lavitrano, Andrew Lewington and Christian Noe), and Maria Teresa De Magistris (IMI project officer) plus colleagues from the IMI-JU. The feedback we received on both the work performed so far and our plans for the coming years was very positive. During the discussion a variety of interesting and constructive proposals were made by the reviewers, which is summarized below.
We would like to take this opportunity to thank all the colleagues having helped so much to thoroughly prepare and run the meeting. It was a substantial effort during the past few weeks, but it definitely paid off!
Ina and Michael
SAFE-T Midterm review at the IMI JU
Final summary and recommendations:
• Great project
• One year extension supported
• Establish best practice document on sampling standards
• Coordinate data and knowledge management across IMI consortia
• Align activities across safety related IMI consortia
• Switch some of the preclinical activities to clinical work. Rather use synergies with PSTC to cover preclinical work.
• Publish standard monographs on assays
• Establish flexible budget bucket to be managed by the coordinators
• Reconsider conduct of Acetaminophen challenge study, would have significant value for DILI BM qualification.
• Clarify IP concerns of SMEs, as well as potential products and services of SMEs as outcome from SAFE-T, task for WP8.
• Try to reinforce contribution from EFPIA partners as per original commitments.
• Consider e-mail communication to biomarker Key opinion leaders to increase awareness of and support for SAFE-T.
Back to news list